home intro relationships exercise Sheryl's
lists
managing
symptoms
tips for
getting by
medical
insights
clinical
trials
living
well
get
involved
global
action
2016
WPC

A flaw in the clinical trial system

I’ve long been a supporter of clinical trial participation, but I recognize that there is a flaw in the system, and it is time for a change. Even so, when the folks at the NIH asked me to speak about clinical trial participation, I was happy to do so. You can view my interview at right.

The first trial I was in ended abruptly after three years with a single posting on a website. None of the patient participants were notified about its ending. At the time, it was considered a scandal within the research community.

After the end of that first trial, about 575 of us were recruited for a follow-on trial. During my 6 years in the follow-on trial:

  • I had two SPECT scans
  • I had 6 annual neurological exams
  • I gave blood
  • I took 6 smell tests
  • My husband and I participated in the PROBE trial
  • I participated annually in the FOUND clinical trial
  • and more

I stumbled across a webinar titled, How Completed PD Clinical Studies Help Shape the Future. In it I learned that my data from the follow-on trial has been used to search for biomarkers in:

  • Olfaction
  • Transcriptomics
  • Blood Synuclein
  • Proteomics DNA
  • B-CIT SPECT Imaging
  • Metabolomics

top

 

 

Fox Trial Finder - be part of the solution!

 

So what is the flaw in the system?

I see scientists and researchers sharing information with everyone except the members of their team who made it all possible:  the clinical trial participants. Everything I have learned is from Internet searches — including the fact that the follow-on trial will not continue, due to lack of funding.

So to the PD scientific community, I say: "It is time for change. Clinical trial participants are not lab rats. We are not mute primates. If you want to enhance the recruitment and retention of clinical trial participants, then you need to treat us like the valuable members of the research team that we are. We entrust you with our lives, and all we ask in return is that you treat us with respect and dignity. When you share information learned from our data with scientists and researchers, include us. And yes, be sure to tell us when the clinical trial is going to end."

jean


contact-us

 

email us directly at: Sheryl@pdplan4life.com

(c) 2015 PDPlan LLC All Rights Reserved

Without express written consent, this material may only be used for your own personal and noncommercial uses which do not harm the reputation of PDPlan LLC, provided that you do not remove any copyright. To request permission to reproduce, please contact PDPlan LLC at Sheryl@pdplan4life.com

blogger partner WPC 2016 in Portland